Christopher Starr

Nov 9, 2023 | eyetube.net | I. Paul Singh |Christopher Starr

Innovations in Ocular Surface Disease: What is the Impact of Lifestyle? I. Paul Singh, MD; and Christopher E. Starr, MD Lifestyle is a broadly defined term comprising the influences of personal choices, environmental factors, and daily decisions. But how does all of that affect the health of the ocular surface? In this episode, Christopher E. Starr, MD, joins I. Paul Singh, MD, for an in-depth discussion about the global TFOS Lifestyle Workshop and its work to try and answer that question.

Sep 21, 2023 | dovepress.com | Christopher Starr |Kelly Nichols |Jacob Lang |Todd Brady

IntroductionReproxalap, a novel chemical entity in late-stage clinical development for the treatment of ocular inflammation, chemically sequesters a class of small molecules known as reactive aldehyde species (RASP).